Mabrouk Bahloul

Mabrouk Bahloul

Auto-generated profile, based on publicly available information

Mabrouk Bahloul


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2003 in Chest
Verified
Journal Article
Closed access
FMFrédéric Michard
Frédéric Michard
SASami Alaya
Sami Alaya
VZVéronique Zarka
Véronique Zarka
MBMabrouk Bahloul
Mabrouk Bahloul
CRChristian Richard
Christian Richard
JTJean Louis Teboul
Jean Louis Teboul

8 February 2002 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
AMArmand Mekontso-Dessap
Armand Mekontso-Dessap
VCVincent Castelain
Vincent Castelain
NANadia Anguel
Nadia Anguel
MBMabrouk Bahloul
Mabrouk Bahloul
FSFranck Schauvliege
Franck Schauvliege
JTJean Louis Teboul
Jean Louis Teboul

25 May 2007 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
HKHatem Kallel
Hatem Kallel
LHL. Hergafi
L. Hergafi
MBM. Bahloul
M. Bahloul
AHA. Hakim
A. Hakim
HDH. Dammak
H. Dammak
MBM. Bouaziz
M. Bouaziz

1 October 2006 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
HKHatem Kallel
Hatem Kallel
MBMabrouk Bahloul
Mabrouk Bahloul
LHLeila Hergafi
Leila Hergafi
MAMalek Akrout
Malek Akrout
WKWajdi Ketata
Wajdi Ketata
MBMounir Bouaziz
Mounir Bouaziz

1 December 2008 in Toxicon
Verified
Journal Article
Closed access
MBMounir Bouaziz
Mounir Bouaziz
MBMabrouk Bahloul
Mabrouk Bahloul
HKHatem Kallel
Hatem Kallel
MSMohamed Samet
Mohamed Samet
HKHichem Ksibi
Hichem Ksibi
NRNoureddine Rekik
Noureddine Rekik

5 November 2010 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
MBMabrouk Bahloul
Mabrouk Bahloul
ICImen Chabchoub
Imen Chabchoub
ACAnis Chaari
Anis Chaari
KCKamilia Chtara
Kamilia Chtara
HKHatem Kallel
Hatem Kallel
MBMounir Bouaziz
Mounir Bouaziz
Our objective was to characterize both epidemiologically and clinically manifestations after severe scorpion envenomation and to define simple factors indicative of poor prognosis in children. We performed a retrospective study over 13 years (1990–2002) in the medical intensive care unit (ICU) of a university hospital (Sfax-Tunisia). The diagnosis of scorpion envenomation was based on a history of scorpion sting. The medical records of 685 children aged less than 16 years who were admitted for a scorpion sting were analyzed. There were 558 patients (81.5%) in the grade III group (with cardiogenic shock and/or pulmonary edema or severe neurological manifestation [coma and/or convulsion]) and 127 patients (18.5%) in the grade II group (with systemic manifestations). In this study, 434 patients (63.4%) had a pulmonary edema, and 80 patients had a cardiogenic shock; neurological manifestations were observed in 580 patients (84.7%), 555 patients (81%) developed systemic inflammatory response syndrome (SIRS), and 552 patients (80.6%) developed multi-organ failure. By the end of the stay in the ICU, evolution was marked by the death in 61 patients (8.9%). A multivariate analysis found the following factors to be correlated with a poor outcome: coma with Glasgow coma score ≤ 8/15 (odds ratio [OR] = 1.3), pulmonary edema (OR = 2.3), and cardiogenic shock (OR = 1.7). In addition, a significant association was found between the development of SIRS and heart failure. Moreover, a temperature > 39°C was associated with the presence of pulmonary edema, with a sensitivity at 20.6%, a specificity at 94.4%, and a positive predictive value at 91.7%. Finally, blood sugar levels above 15 mmol/L were significantly associated with a heart failure. In children admitted for severe scorpion envenomation, coma with Glasgow coma score ≤ 8/15, pulmonary edema, and cardiogenic shock were associated with a poor outcome. The presence of SIRS, a temperature > 39°C, and blood sugar levels above 15 mmol/L were associated with heart failure.